NCT06036056 NMR Based Metabolomics Kinetics in ARDS Patients
| NCT ID | NCT06036056 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sanjay Gandhi Postgraduate Institute of Medical Sciences |
| Condition | ARDS |
| Study Type | OBSERVATIONAL |
| Enrollment | 120 participants |
| Start Date | 2023-09-13 |
| Primary Completion | 2025-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 120 participants in total. It began in 2023-09-13 with a primary completion date of 2025-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Acute respiratory distress syndrome (ARDS) is a life-threatening condition requiring respiratory support to maintain oxygenation. Very few biomarkers about ARDS have been identified but none of them has a sufficient specificity or sensitivity to characterize by itself the severity of lung condition. Investigators hypothesize that there is considerable change occurring in metabolic profiles in mild, moderate, and severe ARDS in comparison to healthy cohort, which can be detectable through serum analysis using NMR based metabolomics study. This research would help to understand metabolomics kinetics during the ARDS disease progression. Overall, NMR-based metabolomics study would provide an insight into the mediators involved in pathogenesis and progression of ARDS.
Eligibility Criteria
Inclusion Criteria: * Critically ill adult patients having mild ARDS with onset less than 72 hours Exclusion Criteria: * Age less than 18 years or more than 65 years * Expected survival \<72 hours * Refusal from family member
Contact & Investigator
Neeraj Sinha, M.Sc., Ph.D.
PRINCIPAL INVESTIGATOR
Centre of Biomedical Research
Frequently Asked Questions
Who can join the NCT06036056 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying ARDS. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06036056 currently recruiting?
Yes, NCT06036056 is actively recruiting participants. Contact the research team at m.gurjar@rediffmail.com for enrollment information.
Where is the NCT06036056 trial being conducted?
This trial is being conducted at Lucknow, India.
Who is sponsoring the NCT06036056 clinical trial?
NCT06036056 is sponsored by Sanjay Gandhi Postgraduate Institute of Medical Sciences. The principal investigator is Neeraj Sinha, M.Sc., Ph.D. at Centre of Biomedical Research. The trial plans to enroll 120 participants.